Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab

By afschroeder • October 23, 2025

Karapetians AG, Ayyagari T, Montana W. Epstein-Barr Virus-Positive Lymphoproliferative Disorder in an HIV Patient Successfully Treated With Rituximab. Cureus. 2025 Sep 21;17(9):e92816. doi: 10.7759/cureus.92816. PMID: 41127741; PMCID: PMC12538195.

Tags: ebv in hiv positive, ebv positive, ebv ptld, ebv-positive b-cell lymphoproliferative disease, ebv-positive lymphoproliferative disorder, ebv-positive mucocutaneous ulcer, epstein-barr virus (ebv), Hematology/Oncology, Kern, Publications, rituximab monotherapy, rituximab therapy

Related Posts

Clinical Outcomes of Older Patients with NPM1-Mutated or KMT2A-Rearranged AML Before Menin Inhibitors: A Beat AML Report

Zeidner JF, Jain J, Welkie RL, Huang Y, Swords R, Traer E, Stein EM, Lin TL, Madanat YF, Collins RH Jr, Baer MR, Duong VH,[...]

Linking Baseline PSMA PET-Derived Parameters to Toxicity, Adverse Events, Pain, and Quality of Life in Patients Treated with [177Lu]Lu-PSMA-617: A Single-Center Retrospective Study

Murthy V, Kimura K, Theus L, Nguyen A, Grogan TR, Lokre O, Perk T, Rettig MB, Drakaki A, Shen J, Thin P, Nguyen K, Lira[...]

Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial

Wainberg ZA, Link JM, Premji A, Zheng S, Srienc M, Hammons M, Kim SE, Li L, Liu Z, Tsvetkova O, Abt ER, Rosen L, Kim[...]